about
A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation NecrosisATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological featuresCombined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyA phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies.Body mass index, diabetes, and triple-negative breast cancer prognosis.In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages.Predicting Clinical Binary Outcome Using Multivariate Longitudinal Data: Application to Patients with Newly Diagnosed Primary Open-Angle Glaucoma.Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer.Diagnostic Utility of Gene Expression Profiles.Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.Sentinel lymph nodes and lymphatic vessels: noninvasive dual-modality in vivo mapping by using indocyanine green in rats--volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging.The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy.Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myelomaSrc homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancerAnti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.Intraoperative magnetic resonance imaging to reduce the rate of early reoperation for lesion resection in pediatric neurosurgery.Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancerPrognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysisA joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome.DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.The value of perioperative imaging in patients with uterine sarcomasA GSK-3β inhibitor protects against radiation necrosis in mouse brain.Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical modelsSafety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancerImpact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreasAdjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.US breast cancer mortality trends in young women according to racePreclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.Atypical squamous cells of undetermined significance in girls and women.A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinomaPanniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms.Patient preference and recall of results of EUS-guided FNAHigh-dose therapy and autologous stem cell transplant in older adults with multiple myeloma.
P50
Q27315120-F5E41470-86A8-46B7-906B-7E852D90A90BQ27851472-2B23C4AA-9CE9-4D55-8DD6-1D22D0D221DFQ28731816-46995F88-9169-4803-A205-06C259ECFD5AQ30361978-526BF2E7-A4ED-46A9-8442-CADFAF79F1EEQ30411680-622F4321-F655-425F-B4D6-B0DB3B291209Q30458239-18C68610-770E-43CF-ACA7-09FC435ADF99Q30499160-ADC843C7-0FE0-49F1-8C7A-ED6656007DF4Q31048408-61C75CC9-E3A9-4981-84E0-FCE8EB6CD89FQ33407093-23B19474-6ECA-45CC-AF9D-595F23BB3BB4Q33410746-4A6CAA8C-3CDC-424B-9E5B-42CF7AF85760Q33632055-BA4AD36A-86EA-493B-83E8-1E2408CE946FQ33637997-B4C08EF1-CDAB-479D-89A9-2F2CD17E232CQ33670824-124EA844-BAB5-4051-B00B-A0576F263A3EQ33705413-D9A95C02-D64B-4351-800C-183E2D833E2FQ33807169-F21DD1B1-2C61-4A64-8F98-E2B4476D5590Q33842065-5642F8B0-9A7A-46A4-AA9E-3F6289F5CFC0Q33845985-CBA36E54-7C81-4FBB-8B1F-711C8AF53396Q33910069-61C05787-E185-4DF2-9E17-C9DBBF1E7CA1Q34054649-0690C899-FAE1-4D89-8EC5-20137D947979Q34180530-85361C45-A6D5-4781-A36C-B00683C21CFDQ34270064-902FEF20-34B6-45BB-8F2C-FFF3068922A9Q34415427-A1C12AB4-DF18-4EFA-9D63-F6003337243FQ34433542-99F000ED-140F-403F-ADD3-060E563D9325Q34577844-A86F5E0F-1A6C-44EF-A900-1B9148B7BC84Q34731304-9817E876-2755-49A6-A09F-B5A173483822Q35013662-E7D76104-E3D3-4B24-BBFD-0A2DA317407DQ35018692-653D42BC-6695-421F-945A-856259D6D461Q35018805-AB688602-F6E5-4034-AB3B-53F6C0DE0E49Q35065923-8B3D766A-9299-4061-9E31-C2C3E01817A4Q35235483-A957EE1E-E5C2-4DB9-BF2E-E755CE943CF9Q35244224-65052375-62BB-42AC-847F-AE0C0A73011AQ35250502-3C613E8E-BC86-41AE-A4BB-B4648CB7D579Q35536998-9AFBC46F-0254-4897-B489-D8B8B4074718Q35558909-F82A7BE4-FD2D-490E-BD8C-0D5CE81A52DDQ35623021-0E8DF35C-6041-440E-A52C-D607ABE1108AQ35722607-C5494C68-1CAA-4852-927F-055309B060AEQ35761097-C9189B05-A733-443C-87EF-09A186BB7B8FQ35857239-142B02BA-796E-48B1-8C61-DE2C7994E6E7Q35857552-EF586A68-610F-464B-B39C-F6743C887164Q35920754-3F1EF6C0-1576-4E8D-82E9-073AD20321AB
P50
description
researcher ORCID: 0000-0002-1425-1623
@en
name
Feng Gao
@ast
Feng Gao
@en
Feng Gao
@es
Feng Gao
@nl
Feng Gao
@sl
type
label
Feng Gao
@ast
Feng Gao
@en
Feng Gao
@es
Feng Gao
@nl
Feng Gao
@sl
prefLabel
Feng Gao
@ast
Feng Gao
@en
Feng Gao
@es
Feng Gao
@nl
Feng Gao
@sl
P106
P1153
56443108400
P2456
P31
P496
0000-0002-1425-1623